EP Wealth Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

EP Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$321K	Buy	9,464 +2,078	+28%	+$69.2K	﹤0.01%	1253
2026 Q1	$222K	Sell	7,386 -1,681	-19%	-$54.1K	﹤0.01%	1348
2025 Q4	$283K	Buy	+9,067	New	+$223K	﹤0.01%	1172
2025 Q2	–	Sell	-22,806	Closed	-$351K	–	1473
2025 Q1	$351K	Sell	22,806 -1,146	-5%	-$20.5K	﹤0.01%	840
2024 Q4	$528K	Sell	23,952 -1,190	-5%	-$21.6K	﹤0.01%	676
2024 Q3	$453K	Buy	+25,142	New	+$440K	﹤0.01%	721

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

EP Wealth Advisors's TEVA Position: Q2 2026 in Review

EP Wealth Advisors increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 28% in Q2 2026, buying an estimated $69.2K and bringing the position to 9,464 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #1253.

EP Wealth Advisors first reported a position in TEVA in Q3 2024 and has held it in 6 quarters since. The position peaked at $528K in Q4 2024. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

EP Wealth Advisors held 9,464 shares of Teva Pharmaceutical Industries Limited worth $321K as of Q2 2026.
EP Wealth Advisors bought 2,078 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $69.2K.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of EP Wealth Advisors's portfolio in Q2 2026, its #1253 holding.
EP Wealth Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q3 2024 and has held it in 6 quarters since.
EP Wealth Advisors's Teva Pharmaceutical Industries Limited position peaked at $528K in Q4 2024.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.